Kane Biotech Croissance FCF

Que fait Kane Biotech ? Kane Biotech Inc is a biotechnology company based in Winnipeg, Manitoba, Canada. The company went public on May 7, 2003, with its stock ticker KNE.V and ISIN CA4838092084. Kane Biotech focuses on researching, developing, and commercializing technologies and products designed to prevent and remove microbial biofilms. The company's product portfolio includes StrixNB, DispersinB, Aledex, bluestem (available in water additives, chews, spray, and dental wipes), silkstem, goldstem, coactiv+, and DermaKB Biofilm. Its Wound Care & Surgical division is developing DispersinB for chronic wound care applications. The company also offers products such as Scalp Detoxifier, Shampoo, and Shampoo Bars. Kane Biotech's primary market focus is on animal health, though it also develops products for human wound care and surgical applications. The company's product development includes Coactiv+ as an antimicrobial wound rinse and surgical hydrogel, as well as DispersinB Gel for prosthetic joint infections. Kane Biotech operates within the Health Care sector, specifically in the Biotechnology industry. The company's website is https://kanebiotech.com/ and it is headquartered in Winnipeg, Canada. Kane Biotech est l'une des entreprises les plus populaires sur Eulerpool.